Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
FL is the most common slow-growing B-cell non-Hodgkin lymphoma form. Minjuvi is ...
This is claimed to become the first fully dedicated small-interfering RNA (siRNA...
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final ...
Harbour BioMed will work alongside BMS to progress and expedite the programmes a...
Senores Pharmaceuticals announced that it has entered into a definitive agreeme...
Lupin has announced that the Committee for Medicinal Products for Human Use (CH...
The company’s plans are expected to increase the capacity for injectable drug pr...
RPG Life Sciences, the leading pharmaceutical company of RPG Group, today annou...
Agilent Technologies, a global leader in life sciences, diagnostics, and applie...
AstraZeneca announced new Phase III clinical data for baxdrostat, an investigat...
The 24th IDMA Pharmaceutical Analysts’ Conference (PAC) commenced on December 1...
“Odisha will be a leading destination for pharmaceutical and medical‑device inv...
The expansion is targeted at individuals for whom topical corticosteroids are no...
The investment values Swixx at more than €1.5bn ($1.76bn). Swixx operates as a c...
Adarsh Padmanabha highlights how cold-chain-ready, in-city warehousing is resha...
Unified summit to bring biologics and 3D cell culture communities on a single p...
